Global Anti-tumor Drug Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 07-Aug-2018
No. of pages: 153

Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.

Scope of the Report:

This report studies the Anti-tumor Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Anti-tumor Drug market by product type and applications/end industries.

In China, antitumor drugs are also the key areas of concern for many enterprises. Such as Jiangsu Hengrui, Qilu Pharmaceutical and other well-known domestic enterprises in the anti-tumor drugs have invested a lot of money, there are many innovative anti-cancer drugs into the clinical research stage. In the meantime, there has been "explosive" growth in the development of molecularly targeted drugs, with at least hundreds of drugs under development, and it is conceivable that the market will be quite crowded in the next five to 10 years. Therefore, domestic enterprises should fully understand the feasibility of the project and the fierce market competition that they may face in the future.

China's bio-pharmaceutical industry already has a good foundation; from the national level to local governments at all levels continue to step up efforts to support the development of bio-pharmaceutical industry. The output value of the pharmaceutical industry maintained a growth rate of 20% during the 12th Five-Year Plan period. In 2013, the total output value of the pharmaceutical industry reached 2.1 trillion yuan. However, compared with the bio-pharmaceutical industry in the advanced countries in the world, there is still a huge gap between the biomedical industry in our country and the demand for building an overall well-to-do society. Mainly manifested in: small-scale enterprises, more than 10 billion yuan enterprises and more than one billion yuan less; independent innovation ability is weak, many varieties of imitation with independent intellectual property rights of the few species; restrict some of the long-term development of biomedical industry , Deep-seated problems still exist.

The global Anti-tumor Drug market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Anti-tumor Drug.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

- Roche

- Novartis

- Celgene

- Bristol-Myers Squibb

- Amgen

- Johnson & Johnson

- Pfizer

- Takeda

- Eli Lilly

- AstraZeneca

- Astellas

- Merck & Co

- Sanofi

- Bayer

- Biogen Idec

- Eisai

- Teva

- Otsuka

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Cytotoxic Drugs

- Non-cytotoxic Drugs

Market Segment by Applications, can be divided into

- Alkylating Agents

- Anti-metabolism Drugs

- Platinum Antineoplastic Agents

- Anthracycline antitumor drugs

- Microtubule Stabilizer

- Endocrine Therapy Drugs

- Immunotherapy Drugs

- Gene Therapy Drugs

- Targeted Antineoplastic Drugs

Global Anti-tumor Drug Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

1 Anti-tumor Drug Market Overview
1.1 Product Overview and Scope of Anti-tumor Drug
1.2 Classification of Anti-tumor Drug by Types
1.2.1 Global Anti-tumor Drug Revenue Comparison by Types (2017-2023)
1.2.2 Global Anti-tumor Drug Revenue Market Share by Types in 2017
1.2.3 Cytotoxic Drugs
1.2.4 Non-cytotoxic Drugs
1.3 Global Anti-tumor Drug Market by Application
1.3.1 Global Anti-tumor Drug Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Alkylating Agents
1.3.3 Anti-metabolism Drugs
1.3.4 Platinum Antineoplastic Agents
1.3.5 Anthracycline antitumor drugs
1.3.6 Microtubule Stabilizer
1.3.7 Endocrine Therapy Drugs
1.3.8 Immunotherapy Drugs
1.3.9 Gene Therapy Drugs
1.3.10 Targeted Antineoplastic Drugs
1.4 Global Anti-tumor Drug Market by Regions
1.4.1 Global Anti-tumor Drug Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Anti-tumor Drug Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Anti-tumor Drug Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-tumor Drug Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Anti-tumor Drug Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-tumor Drug Status and Prospect (2013-2023)
1.5 Global Market Size of Anti-tumor Drug (2013-2023)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Anti-tumor Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Anti-tumor Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celgene
2.3.1 Business Overview
2.3.2 Anti-tumor Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Anti-tumor Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.5 Amgen
2.5.1 Business Overview
2.5.2 Anti-tumor Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Anti-tumor Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Anti-tumor Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.8 Takeda
2.8.1 Business Overview
2.8.2 Anti-tumor Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Anti-tumor Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Anti-tumor Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.11 Astellas
2.11.1 Business Overview
2.11.2 Anti-tumor Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.12 Merck & Co
2.12.1 Business Overview
2.12.2 Anti-tumor Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sanofi
2.13.1 Business Overview
2.13.2 Anti-tumor Drug Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.14 Bayer
2.14.1 Business Overview
2.14.2 Anti-tumor Drug Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.15 Biogen Idec
2.15.1 Business Overview
2.15.2 Anti-tumor Drug Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.16 Eisai
2.16.1 Business Overview
2.16.2 Anti-tumor Drug Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.17 Teva
2.17.1 Business Overview
2.17.2 Anti-tumor Drug Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
2.18 Otsuka
2.18.1 Business Overview
2.18.2 Anti-tumor Drug Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-tumor Drug Market Competition, by Players
3.1 Global Anti-tumor Drug Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Anti-tumor Drug Players Market Share
3.2.2 Top 10 Anti-tumor Drug Players Market Share
3.3 Market Competition Trend
4 Global Anti-tumor Drug Market Size by Regions
4.1 Global Anti-tumor Drug Revenue and Market Share by Regions
4.2 North America Anti-tumor Drug Revenue and Growth Rate (2013-2018)
4.3 Europe Anti-tumor Drug Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-tumor Drug Revenue and Growth Rate (2013-2018)
4.5 South America Anti-tumor Drug Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-tumor Drug Revenue and Growth Rate (2013-2018)
5 North America Anti-tumor Drug Revenue by Countries
5.1 North America Anti-tumor Drug Revenue by Countries (2013-2018)
5.2 USA Anti-tumor Drug Revenue and Growth Rate (2013-2018)
5.3 Canada Anti-tumor Drug Revenue and Growth Rate (2013-2018)
5.4 Mexico Anti-tumor Drug Revenue and Growth Rate (2013-2018)
6 Europe Anti-tumor Drug Revenue by Countries
6.1 Europe Anti-tumor Drug Revenue by Countries (2013-2018)
6.2 Germany Anti-tumor Drug Revenue and Growth Rate (2013-2018)
6.3 UK Anti-tumor Drug Revenue and Growth Rate (2013-2018)
6.4 France Anti-tumor Drug Revenue and Growth Rate (2013-2018)
6.5 Russia Anti-tumor Drug Revenue and Growth Rate (2013-2018)
6.6 Italy Anti-tumor Drug Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Anti-tumor Drug Revenue by Countries
7.1 Asia-Pacific Anti-tumor Drug Revenue by Countries (2013-2018)
7.2 China Anti-tumor Drug Revenue and Growth Rate (2013-2018)
7.3 Japan Anti-tumor Drug Revenue and Growth Rate (2013-2018)
7.4 Korea Anti-tumor Drug Revenue and Growth Rate (2013-2018)
7.5 India Anti-tumor Drug Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-tumor Drug Revenue and Growth Rate (2013-2018)
8 South America Anti-tumor Drug Revenue by Countries
8.1 South America Anti-tumor Drug Revenue by Countries (2013-2018)
8.2 Brazil Anti-tumor Drug Revenue and Growth Rate (2013-2018)
8.3 Argentina Anti-tumor Drug Revenue and Growth Rate (2013-2018)
8.4 Colombia Anti-tumor Drug Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Anti-tumor Drug by Countries
9.1 Middle East and Africa Anti-tumor Drug Revenue by Countries (2013-2018)
9.2 Saudi Arabia Anti-tumor Drug Revenue and Growth Rate (2013-2018)
9.3 UAE Anti-tumor Drug Revenue and Growth Rate (2013-2018)
9.4 Egypt Anti-tumor Drug Revenue and Growth Rate (2013-2018)
9.5 Nigeria Anti-tumor Drug Revenue and Growth Rate (2013-2018)
9.6 South Africa Anti-tumor Drug Revenue and Growth Rate (2013-2018)
10 Global Anti-tumor Drug Market Segment by Type
10.1 Global Anti-tumor Drug Revenue and Market Share by Type (2013-2018)
10.2 Global Anti-tumor Drug Market Forecast by Type (2018-2023)
10.3 Cytotoxic Drugs Revenue Growth Rate (2013-2023)
10.4 Non-cytotoxic Drugs Revenue Growth Rate (2013-2023)
11 Global Anti-tumor Drug Market Segment by Application
11.1 Global Anti-tumor Drug Revenue Market Share by Application (2013-2018)
11.2 Anti-tumor Drug Market Forecast by Application (2018-2023)
11.3 Alkylating Agents Revenue Growth (2013-2018)
11.4 Anti-metabolism Drugs Revenue Growth (2013-2018)
11.5 Platinum Antineoplastic Agents Revenue Growth (2013-2018)
11.6 Anthracycline antitumor drugs Revenue Growth (2013-2018)
11.7 Microtubule Stabilizer Revenue Growth (2013-2018)
11.8 Endocrine Therapy Drugs Revenue Growth (2013-2018)
11.9 Immunotherapy Drugs Revenue Growth (2013-2018)
11.10 Gene Therapy Drugs Revenue Growth (2013-2018)
11.11 Targeted Antineoplastic Drugs Revenue Growth (2013-2018)
12 Global Anti-tumor Drug Market Size Forecast (2018-2023)
12.1 Global Anti-tumor Drug Market Size Forecast (2018-2023)
12.2 Global Anti-tumor Drug Market Forecast by Regions (2018-2023)
12.3 North America Anti-tumor Drug Revenue Market Forecast (2018-2023)
12.4 Europe Anti-tumor Drug Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Anti-tumor Drug Revenue Market Forecast (2018-2023)
12.6 South America Anti-tumor Drug Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Anti-tumor Drug Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Anti-tumor Drug Picture
Table Product Specifications of Anti-tumor Drug
Table Global Anti-tumor Drug and Revenue (Million USD) Market Split by Product Type
Figure Global Anti-tumor Drug Revenue Market Share by Types in 2017
Figure Cytotoxic Drugs Picture
Figure Non-cytotoxic Drugs Picture
Table Global Anti-tumor Drug Revenue (Million USD) by Application (2013-2023)
Figure Anti-tumor Drug Revenue Market Share by Applications in 2017
Figure Alkylating Agents Picture
Figure Anti-metabolism Drugs Picture
Figure Platinum Antineoplastic Agents Picture
Figure Anthracycline antitumor drugs Picture
Figure Microtubule Stabilizer Picture
Figure Endocrine Therapy Drugs Picture
Figure Immunotherapy Drugs Picture
Figure Gene Therapy Drugs Picture
Figure Targeted Antineoplastic Drugs Picture
Table Global Market Anti-tumor Drug Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Anti-tumor Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Anti-tumor Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Anti-tumor Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Anti-tumor Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Anti-tumor Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Anti-tumor Drug Revenue (Million USD) and Growth Rate (2013-2023)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Anti-tumor Drug Type and Applications
Table Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Anti-tumor Drug Type and Applications
Table Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Anti-tumor Drug Type and Applications
Table Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Anti-tumor Drug Type and Applications
Table Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Anti-tumor Drug Type and Applications
Table Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Anti-tumor Drug Type and Applications
Table Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Anti-tumor Drug Type and Applications
Table Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Anti-tumor Drug Type and Applications
Table Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Anti-tumor Drug Type and Applications
Table Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Anti-tumor Drug Type and Applications
Table AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Anti-tumor Drug Type and Applications
Table Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co Basic Information, Manufacturing Base and Competitors
Table Merck & Co Anti-tumor Drug Type and Applications
Table Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Anti-tumor Drug Type and Applications
Table Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Anti-tumor Drug Type and Applications
Table Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Anti-tumor Drug Type and Applications
Table Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Anti-tumor Drug Type and Applications
Table Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Anti-tumor Drug Type and Applications
Table Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Anti-tumor Drug Type and Applications
Table Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Global Anti-tumor Drug Revenue (Million USD) by Players (2013-2018)
Table Global Anti-tumor Drug Revenue Share by Players (2013-2018)
Figure Global Anti-tumor Drug Revenue Share by Players in 2016
Figure Global Anti-tumor Drug Revenue Share by Players in 2017
Figure Global Top 5 Players Anti-tumor Drug Revenue Market Share in 2017
Figure Global Top 10 Players Anti-tumor Drug Revenue Market Share in 2017
Figure Global Anti-tumor Drug Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Anti-tumor Drug Revenue (Million USD) by Regions (2013-2018)
Table Global Anti-tumor Drug Revenue Market Share by Regions (2013-2018)
Figure Global Anti-tumor Drug Revenue Market Share by Regions (2013-2018)
Figure Global Anti-tumor Drug Revenue Market Share by Regions in 2017
Figure North America Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Europe Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure South America Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Table North America Anti-tumor Drug Revenue by Countries (2013-2018)
Table North America Anti-tumor Drug Revenue Market Share by Countries (2013-2018)
Figure North America Anti-tumor Drug Revenue Market Share by Countries (2013-2018)
Figure North America Anti-tumor Drug Revenue Market Share by Countries in 2017
Figure USA Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Canada Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Mexico Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Table Europe Anti-tumor Drug Revenue (Million USD) by Countries (2013-2018)
Figure Europe Anti-tumor Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Anti-tumor Drug Revenue Market Share by Countries in 2017
Figure Germany Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure UK Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure France Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Russia Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Italy Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Anti-tumor Drug Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Anti-tumor Drug Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Anti-tumor Drug Revenue Market Share by Countries in 2017
Figure China Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Japan Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Korea Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure India Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Table South America Anti-tumor Drug Revenue by Countries (2013-2018)
Table South America Anti-tumor Drug Revenue Market Share by Countries (2013-2018)
Figure South America Anti-tumor Drug Revenue Market Share by Countries (2013-2018)
Figure South America Anti-tumor Drug Revenue Market Share by Countries in 2017
Figure Brazil Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Argentina Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Colombia Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Anti-tumor Drug Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Anti-tumor Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-tumor Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Anti-tumor Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure UAE Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Egypt Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure Nigeria Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Figure South Africa Anti-tumor Drug Revenue and Growth Rate (2013-2018)
Table Global Anti-tumor Drug Revenue (Million USD) by Type (2013-2018)
Table Global Anti-tumor Drug Revenue Share by Type (2013-2018)
Figure Global Anti-tumor Drug Revenue Share by Type (2013-2018)
Figure Global Anti-tumor Drug Revenue Share by Type in 2017
Table Global Anti-tumor Drug Revenue Forecast by Type (2018-2023)
Figure Global Anti-tumor Drug Market Share Forecast by Type (2018-2023)
Figure Global Cytotoxic Drugs Revenue Growth Rate (2013-2018)
Figure Global Non-cytotoxic Drugs Revenue Growth Rate (2013-2018)
Table Global Anti-tumor Drug Revenue by Application (2013-2018)
Table Global Anti-tumor Drug Revenue Share by Application (2013-2018)
Figure Global Anti-tumor Drug Revenue Share by Application (2013-2018)
Figure Global Anti-tumor Drug Revenue Share by Application in 2017
Table Global Anti-tumor Drug Revenue Forecast by Application (2018-2023)
Figure Global Anti-tumor Drug Market Share Forecast by Application (2018-2023)
Figure Global Alkylating Agents Revenue Growth Rate (2013-2018)
Figure Global Anti-metabolism Drugs Revenue Growth Rate (2013-2018)
Figure Global Platinum Antineoplastic Agents Revenue Growth Rate (2013-2018)
Figure Global Anthracycline antitumor drugs Revenue Growth Rate (2013-2018)
Figure Global Microtubule Stabilizer Revenue Growth Rate (2013-2018)
Figure Global Endocrine Therapy Drugs Revenue Growth Rate (2013-2018)
Figure Global Immunotherapy Drugs Revenue Growth Rate (2013-2018)
Figure Global Gene Therapy Drugs Revenue Growth Rate (2013-2018)
Figure Global Targeted Antineoplastic Drugs Revenue Growth Rate (2013-2018)
Figure Global Anti-tumor Drug Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Anti-tumor Drug Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Anti-tumor Drug Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Anti-tumor Drug Revenue Market Forecast (2018-2023)
Figure Europe Anti-tumor Drug Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Anti-tumor Drug Revenue Market Forecast (2018-2023)
Figure South America Anti-tumor Drug Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Anti-tumor Drug Revenue Market Forecast (2018-2023)
  • Global Patient Temperature Management Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 134
    Normally, core body temperature falls between 96.8 °F and 99.5 °F. Patient temperature management enables treatment to a patient by maintaining and achieving core body temperature (normothermia) to avoid hypothermia or hyperthermia. Hypothermia can cause discomfort, prolong healing time, and increase risks during surgeries, while hyperthermia affects the central nervous system. Therefore, hospitals and other healthcare centers adopt patient temperature management systems to control and monitor t......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Patient Temperature Management Devices Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 130
    Normally, core body temperature falls between 96.8 °F and 99.5 °F. Patient temperature management enables treatment to a patient by maintaining and achieving core body temperature (normothermia) to avoid hypothermia or hyperthermia. Hypothermia can cause discomfort, prolong healing time, and increase risks during surgeries, while hyperthermia affects the central nervous system. Therefore, hospitals and other healthcare centers adopt patient temperature management systems to control and monitor t......
  • Global Irreversible Electroporation Ablators Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 111
    Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importa......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Irreversible Electroporation Ablators Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 116
    Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importa......
  • Global Ambulatory Blood Pressure Monitoring Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 131
    Ambulatory BP monitors are fully automatic and can record BP for 24 hours or longer while patients go about their normal daily activities. Monitors measure about 4 by 3 inches and weigh about 4 lbs. They can be worn on a belt or in a pouch and are connected to a sphygmomanometer cuff on the upper arm by a plastic tube. Patients are asked to keep their arm still while the cuff is inflating and to avoid extreme physical exertion while wearing the monitor. Scope of the Report: ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Ambulatory Blood Pressure Monitoring Devices Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 128
    Ambulatory BP monitors are fully automatic and can record BP for 24 hours or longer while patients go about their normal daily activities. Monitors measure about 4 by 3 inches and weigh about 4 lbs. They can be worn on a belt or in a pouch and are connected to a sphygmomanometer cuff on the upper arm by a plastic tube. Patients are asked to keep their arm still while the cuff is inflating and to avoid extreme physical exertion while wearing the monitor. Scope of the Report: ......
  • Global Epileptic Seizure Monitor Alarm System Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 132
    Epileptic Seizure Monitor Alarm System is a seizure-detection system that can be used long-term and in home situations for early intervention and prevention of seizure related side effects including SUDEP (sudden unexpected death in epileptic patients). Scope of the Report: This report focuses on the Epileptic Seizure Monitor Alarm System in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes th......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Epileptic Seizure Monitor Alarm System Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 131
    Epileptic Seizure Monitor Alarm System is a seizure-detection system that can be used long-term and in home situations for early intervention and prevention of seizure related side effects including SUDEP (sudden unexpected death in epileptic patients). Scope of the Report: This report focuses on the Epileptic Seizure Monitor Alarm System in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes th......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Venous Stents Market 2018, Forecast to 2023
    Published: 13-Aug-2018        Price: US 4880 Onwards        Pages: 135
    This report studies the Venous Stents market. Venous stents are metal mesh tubes that expand against blocked or narrowed vein walls. They act as a scaffold to keep veins open. In most cases, surgeons place venous stents in larger, central veins, such as those found in the legs, chest and abdomen. Scope of the Report: This report focuses on the Venous Stents in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This re......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs